Search results
Results from the WOW.Com Content Network
The Sunshine Act requires manufacturers of drugs, medical devices, biological and medical supplies covered by the three federal health care programs Medicare, Medicaid, and State Children's Health Insurance Program (SCHIP) to collect and track all financial relationships with physicians and teaching hospitals and to report these data to the Centers for Medicare and Medicaid Services (CMS).
Aggregate Spend is the process used in the United States to aggregate and monitor the total amount spent by healthcare manufacturers on individual healthcare professionals and organizations (HCP/O) through payments, gifts, honoraria, travel and other means. Also often referred to as the Physician Payments Sunshine Act, this initiative is a ...
Medical–industrial complex. The medical–industrial complex (MIC) refers to a network of interactions between pharmaceutical corporations, health care personnel, and medical conglomerates to supply health care-related products and services for a profit. [1][2] The term is derived from the idea of the military–industrial complex. [3]
Finally, corrupt payments can compromise medical research independence and the standards of scientific integrity. Relevant Federal Anti-Fraud Statutes Several Federal statutes are relevant to manufacturer-physician payment relationships. The False Claims Act is the Federal Government’s primary civil enforcement tool for addressing fraud.
Physicians in general practice also face potential conflicts of interest. [7] For example, the Physician Payments Sunshine Act of 2010 requires that financial relationships of physicians and teaching hospitals with manufacturers be reported and made publicly available via the Open Payments Program website .
t. e. The Government in the Sunshine Act (Pub. L. 94–409, 90 Stat. 1241, enacted September 13, 1976, 5 U.S.C. § 552b) is a U.S. law passed in 1976 that affects the operations of the federal government, Congress, federal commissions, and other legally constituted federal bodies. It is one of a number of Freedom of Information Acts, intended ...
The Bipartisan Health Care Stabilization Act of 2017 (colloquially known as the Alexander-Murray bill) was a 2017 proposed compromise reached by senator and HELP Committee chairman Lamar Alexander and senator and HELP Committee ranking member Patty Murray to amend the Affordable Care Act to fund cost-sharing reductions subsidies. [ 1]
Thomas P. Stossel (September 10, 1941 – September 29, 2019) was an American hematologist, inventor, medical researcher, and writer, who discovered gelsolin and invented the BioAegis technology estate. He was also a professor emeritus of medicine at Harvard Medical School and a professor emeritus of clinical research at the American Cancer ...